• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症治疗后影像学的全面综述:从预期到意外及其他。

Comprehensive review of post-treatment imaging in head and neck cancers: from expected to unexpected and beyond.

机构信息

Department of Radiodiagnosis, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai 400 012, Maharashtra, India.

Faculty of Health and Life Sciences, University of Liverpool, Liverpool, Liverpool L69 3BX, United Kingdom.

出版信息

Br J Radiol. 2024 Dec 1;97(1164):1898-1914. doi: 10.1093/bjr/tqae207.

DOI:10.1093/bjr/tqae207
PMID:39392414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11573130/
Abstract

Head and neck cancer management requires multidisciplinary approach in which radical surgery with or without flap reconstructions and neck dissection, along with radiotherapy (RT)/chemoradiotherapy (CRT) serve as the key components. Neoadjuvant chemotherapy and immunotherapy are used in selected cases based on the institutional preference. Knowledge of expected post-treatment changes on imaging is essential to differentiate it from recurrence. In addition, awareness of various post-treatment complications is imperative for their early detection on imaging. Distorted anatomy after treatment poses diagnostic challenge, hence, proper choice of imaging modality and appropriate timing of scan is pertinent for accurate post-treatment evaluation. In this article, we have comprehensively reviewed expected post-treatment appearances and complications on imaging. We have discussed imaging appearances of recurrences at the primary and lymphnodal sites and discussed documentation of findings using Neck Imaging Reporting and Data Systems (NI-RADS). We have also delved into the patterns of recurrence in human papillomavirus (HPV) positive HNSCC. Furthermore, we have provided flowcharts and discussed recommendations on the site-specific and treatment-related imaging modalities to be used along with their appropriate timing, for adequate evaluation of HNSCC after treatment. In addition, we have also touched upon the role of advanced imaging techniques for post-treatment HNSCC evaluation.

摘要

头颈部癌症的治疗需要多学科方法,其中根治性手术(伴或不伴皮瓣重建和颈部清扫术)联合放疗(RT)/放化疗(CRT)是关键组成部分。根据机构偏好,在选定的病例中使用新辅助化疗和免疫治疗。了解影像学上预期的治疗后变化对于将其与复发区分开来至关重要。此外,了解各种治疗后并发症对于在影像学上早期发现它们至关重要。治疗后解剖结构的变形会带来诊断挑战,因此,选择适当的成像方式和扫描时间对于准确的治疗后评估至关重要。在本文中,我们全面回顾了影像学上预期的治疗后表现和并发症。我们讨论了原发性和淋巴结部位复发的影像学表现,并使用颈部成像报告和数据系统(NI-RADS)讨论了发现的记录。我们还深入研究了 HPV 阳性 HNSCC 中的复发模式。此外,我们提供了流程图,并讨论了针对特定部位和治疗相关的成像方式的建议,以及它们的适当时间,以充分评估治疗后的 HNSCC。此外,我们还探讨了先进的影像学技术在治疗后 HNSCC 评估中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/aa67c54f3adf/tqae207f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/aacc8b60aeef/tqae207f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/d4290f0ab44f/tqae207f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/d631e75c0368/tqae207f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/14bbcfdc540e/tqae207f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/d7b562cf78d5/tqae207f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/031beb362c9f/tqae207f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/6f2acfe06f5e/tqae207f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/470e6bc3aceb/tqae207f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/0607c558bd40/tqae207f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/78e2728ff67b/tqae207f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/a9c5885d8c36/tqae207f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/aa67c54f3adf/tqae207f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/aacc8b60aeef/tqae207f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/d4290f0ab44f/tqae207f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/d631e75c0368/tqae207f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/14bbcfdc540e/tqae207f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/d7b562cf78d5/tqae207f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/031beb362c9f/tqae207f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/6f2acfe06f5e/tqae207f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/470e6bc3aceb/tqae207f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/0607c558bd40/tqae207f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/78e2728ff67b/tqae207f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/a9c5885d8c36/tqae207f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833e/11573130/aa67c54f3adf/tqae207f12.jpg

相似文献

1
Comprehensive review of post-treatment imaging in head and neck cancers: from expected to unexpected and beyond.头颈部癌症治疗后影像学的全面综述:从预期到意外及其他。
Br J Radiol. 2024 Dec 1;97(1164):1898-1914. doi: 10.1093/bjr/tqae207.
2
ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.ACR 颈椎成像报告和数据系统(NI-RADS):ACR NI-RADS 委员会白皮书。
J Am Coll Radiol. 2018 Aug;15(8):1097-1108. doi: 10.1016/j.jacr.2018.05.006. Epub 2018 Jul 6.
3
MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?头颈部癌放化疗后行 MRI 检查:何时为显示最大反应的最佳延迟期?
Eur Radiol. 2021 Dec;31(12):9273-9286. doi: 10.1007/s00330-021-07913-x. Epub 2021 May 19.
4
Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.复发性头颈癌:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S181-S190. doi: 10.1017/S002221511600061X.
5
Best Practices: Application of NI-RADS for Posttreatment Surveillance Imaging of Head and Neck Cancer.最佳实践:颈部影像学报告和数据系统(NI-RADS)在头颈癌治疗后监测成像中的应用
AJR Am J Roentgenol. 2021 Jun;216(6):1438-1451. doi: 10.2214/AJR.20.23841. Epub 2021 Apr 21.
6
Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.NI-RADS 用于评估头颈部鳞癌根治性放化疗后 FDG-PET/CECT 应答的诊断性能
Otolaryngol Head Neck Surg. 2023 Oct;169(4):938-947. doi: 10.1002/ohn.305. Epub 2023 Mar 1.
7
Diagnostic Accuracy of F-FDG-PET/CT and F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描和氟代脱氧葡萄糖正电子发射断层扫描/磁共振成像在放化疗结束后 12 周检测头颈部鳞状细胞癌局部区域复发的诊断准确性:PET/MRI 的单中心经验。
Contrast Media Mol Imaging. 2022 Aug 24;2022:8676787. doi: 10.1155/2022/8676787. eCollection 2022.
8
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.在一项针对原发性未切除、临床中高危头颈癌患者的双盲III期研究(LUX-Head & Neck 2)中,阿法替尼与安慰剂作为放化疗后辅助治疗的比较:一项随机对照试验的研究方案。
Trials. 2014 Nov 29;15:469. doi: 10.1186/1745-6215-15-469.
9
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.用于预测头颈部鳞状细胞癌残留或复发的NI-RADS的初始性能。
AJNR Am J Neuroradiol. 2017 Jun;38(6):1193-1199. doi: 10.3174/ajnr.A5157. Epub 2017 Mar 31.
10
Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.颈部成像报告和数据系统第 3 类监测计算机断层扫描:头颈部鳞状细胞癌的发生率、活检率和预测性能。
Laryngoscope. 2022 Sep;132(9):1792-1797. doi: 10.1002/lary.30025. Epub 2022 Jan 19.

引用本文的文献

1
Radiomics in head and neck squamous cell carcinoma - a leap towards precision oncology.头颈部鳞状细胞癌中的放射组学——向精准肿瘤学迈进的一大步。
J Immunother Cancer. 2025 Apr 23;13(4):e011692. doi: 10.1136/jitc-2025-011692.

本文引用的文献

1
Imaging Features of Postradiotherapy Changes in Head and Neck Cancers.头颈部癌放疗后改变的影像学特征
Indian J Radiol Imaging. 2021 Oct 6;31(3):661-669. doi: 10.1055/s-0041-1735921. eCollection 2021 Jul.
2
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities.定义免疫疗法在局部晚期头颈癌根治性治疗中的作用:前景、挑战与机遇
Front Oncol. 2021 Sep 21;11:738626. doi: 10.3389/fonc.2021.738626. eCollection 2021.
3
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy.
头颈部癌的免疫治疗:从诱导化疗到新辅助免疫治疗的范式转变
Front Oncol. 2021 Sep 6;11:727433. doi: 10.3389/fonc.2021.727433. eCollection 2021.
4
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.HPV 相关口咽癌影像学进展:在放射肿瘤学中的应用。
Semin Radiat Oncol. 2021 Oct;31(4):371-388. doi: 10.1016/j.semradonc.2021.05.001.
5
Surgical Management of Sinonasal Cancers: A Comprehensive Review.鼻窦癌的手术治疗:综述
Cancers (Basel). 2021 Aug 8;13(16):3995. doi: 10.3390/cancers13163995.
6
Perineural spread in head and neck malignancies: imaging findings - an updated literature review.头颈部恶性肿瘤的神经周围扩散:影像学表现——最新文献回顾。
Bosn J Basic Med Sci. 2022 Feb 1;22(1):22-38. doi: 10.17305/bjbms.2021.5897.
7
Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges.头颈部癌的放射治疗与免疫治疗:当前证据与挑战
Front Oncol. 2021 Feb 3;10:608772. doi: 10.3389/fonc.2020.608772. eCollection 2020.
8
Radiation Dose De-Escalation in HPV-Positive Oropharynx Cancer: When Will It Be an Acceptable Standard of Care?人乳头瘤病毒阳性口咽癌的放射剂量递减:何时会成为可接受的护理标准?
J Clin Oncol. 2021 Mar 20;39(9):947-949. doi: 10.1200/JCO.21.00017. Epub 2021 Feb 12.
9
Four Lessons Learned from Complications in Head and Neck Microvascular Reconstructions and Prevention Strategies.头颈部微血管重建并发症的四点经验教训及预防策略
Plast Reconstr Surg Glob Open. 2021 Jan 22;9(1):e3329. doi: 10.1097/GOX.0000000000003329. eCollection 2021 Jan.
10
Intravoxel incoherent motion magnetic resonance imaging: basic principles and clinical applications.体素内不相干运动磁共振成像:基本原理与临床应用
Pol J Radiol. 2020 Nov 18;85:e624-e635. doi: 10.5114/pjr.2020.101476. eCollection 2020.